EDGAR Filing Documents for 0001213900-24-067225

Form 8-K - Current report:

SEC Accession No. 0001213900-24-067225

Filing Date

2024-08-09

Accepted

2024-08-09 17:06:37

Documents

Period of Report

2024-08-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea0210958-8k_nkgen.htm iXBRL	8-K	42753
2	COMMON STOCK PURCHASE WARRANT ISSUED TO CFIC, DATED AUGUST 7, 2024	ea021095801ex4-1_nkgen.htm	EX-4.1	145255
3	PROMISSORY NOTE ISSUED TO CFIC, DATED AUGUST 7, 2024	ea021095801ex10-1_nkgen.htm	EX-10.1	141016
4	SECURITIES PURCHASE AGREEMENT, DATED AUGUST 7, 2024, BY AND BETWEEN CFIC AND THE	ea021095801ex10-2_nkgen.htm	EX-10.2	563770
5	LETTER AGREEMENT AGREEMENT, DATED AUGUST 7, 2024, BY AND BETWEEN CFIC AND THE CO	ea021095801ex10-3_nkgen.htm	EX-10.3	36188
6	SECOND LETTER AGREEMENT, DATED AUGUST 7, 2024, BY AND AMONG METEORA AND THE COMP	ea021095801ex10-4_nkgen.htm	EX-10.4	33680
7	SECOND LETTER AGREEMENT, DATED AUGUST 7, 2024, BY AND BETWEEN SANDIA AND THE COM	ea021095801ex10-5_nkgen.htm	EX-10.5	34449
	Complete submission text file	0001213900-24-067225.txt		1475545

Data Files

Seq	Description	Document	Type	Size
8	XBRL SCHEMA FILE	nkgn-20240807.xsd	EX-101.SCH	3882
9	XBRL DEFINITION FILE	nkgn-20240807_def.xml	EX-101.DEF	26779
10	XBRL LABEL FILE	nkgn-20240807_lab.xml	EX-101.LAB	37008
11	XBRL PRESENTATION FILE	nkgn-20240807_pre.xml	EX-101.PRE	25403
22	EXTRACTED XBRL INSTANCE DOCUMENT	ea0210958-8k_nkgen_htm.xml	XML	6001

Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705

Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830

NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)